Psyence Biomedical PBM
NASDAQ PBM
$3.93 -0.17 (-4.15%)
At close: Aug 20, 2026 · 4:00 PM EDT

Psyence Biomedical Ltd. (PBM) Total Debt (2023 - 2025)

Psyence Biomedical (PBM) posted quarterly Total Debt of $298368.0 for Q3 2025, down 76.19% year-over-year from $1.3 million in Q3 2024, and up 49.11% quarter-over-quarter from $200096.0 in Q1 2025.

Psyence Biomedical Ltd. (PBM) Total Debt (2023 - 2025) Analysis & Trends

Psyence Biomedical's Total Debt history runs 3 years deep, the most recent figure standing at $298368.0 for Q3 2025.

  • In Q3 2025, Total Debt fell 76.19% year-over-year to $298368.0; the TTM figure through Sep 2025 stood at $298368.0 (down 76.19% YoY), while the FY2025 annual figure was $200096.0, down 86.43% from the prior year.
  • Total Debt for Q3 2025 stood at $298368.0, up from $200096.0 in the prior quarter.
  • The five-year high for Total Debt was $1607.8 billion in Q3 2023, with the low at $200096.0 in Q1 2025.
  • The 3-year median for Total Debt is $1.3 million (2024), against an average of $321.6 billion.
  • The sharpest annual moves came in 2024 and 2025: Total Debt slumped 100.0% in 2024, then tumbled 76.19% in 2025.
  • Psyence Biomedical's Total Debt stood at $1607.8 billion in 2023, then plunged by 100.0% to $1.3 million in 2024, then sank by 76.19% to $298368.0 in 2025.
  • Business Quant data shows PBM's Total Debt at $298368.0 in Q3 2025, $200096.0 in Q1 2025, and $1.3 million in Q3 2024.

Peer Comparison

Historic Data

Download Data
DateValue
Sep 30, 2025 298,368.00
Mar 31, 2025 200,096.00
Sep 30, 2024 1.25 Mn
Mar 31, 2024 1.47 Mn
Sep 30, 2023 1,607.77 Bn